Attitudes towards Anti-SARS-CoV2 Vaccination among Healthcare Workers: Results from a National Survey in Italy.


Journal

Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722

Informations de publication

Date de publication:
26 02 2021
Historique:
received: 15 01 2021
revised: 19 02 2021
accepted: 23 02 2021
entrez: 3 3 2021
pubmed: 4 3 2021
medline: 13 3 2021
Statut: epublish

Résumé

Coronavirus disease 2019 (COVID-19) has afflicted tens of millions of people, fostering and unprecedent effort in vaccine development and distribution. Healthcare workers (HCW) play a key role in vaccine promotion and patient guidance, and it is likely that hesitancy among this population will have a major impact on the adoption of a successful immunization policy. To investigate HCW attitudes towards anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) vaccination, we developed an anonymous online cross-sectional survey. 1723 Italian HCW responded. Overall, 1155 (67%) intended to be vaccinated, while 443 (26%) were not sure and 125 (7%) declared refusal. In multivariate analysis, factors associated with hesitancy were using Facebook as the main information source and being a non-physician HCW, while predictors of acceptance included younger age, being in close contact with high-risk groups and having received flu vaccination during the 2019-2020 season. Reasons for hesitancy included lack of trust in vaccine safety (85%) and receiving little (78%) or conflicting (69%) information about vaccines. According to our results, adequate investment in vaccine education for healthcare personnel appears to be urgently needed, prioritizing non-physicians and information quality spread through social media. We hope that our data could help governments and policy-makers to target communication in the ongoing COVID-19 vaccination campaign.

Identifiants

pubmed: 33652829
pii: v13030371
doi: 10.3390/v13030371
pmc: PMC7996832
pii:
doi:

Substances chimiques

COVID-19 Vaccines 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Vaccine. 2010 Oct 8;28(43):7030-4
pubmed: 20817011
Emerg Infect Dis. 2019 Jan;25(1):1-4
pubmed: 30560777
Lancet Public Health. 2020 May;5(5):e279-e288
pubmed: 32311320
J Community Health. 2020 Aug;45(4):675-683
pubmed: 32440724
Nature. 2020 Aug;584(7820):257-261
pubmed: 32512579
Bull World Health Organ. 2008 Feb;86(2):140-6
pubmed: 18297169
Euro Surveill. 2019 Jun;24(26):
pubmed: 31266587
JAMA. 2020 Nov 24;324(20):2095-2096
pubmed: 33074293
Nat Rev Immunol. 2020 Oct;20(10):615-632
pubmed: 32887954
Eur J Health Econ. 2020 Sep;21(7):977-982
pubmed: 32591957
Expert Rev Vaccines. 2015 Jan;14(1):99-117
pubmed: 25373435
Lancet Infect Dis. 2021 Feb;21(2):193-202
pubmed: 33729915
J Infect. 2010 Sep;61(3):252-8
pubmed: 20600304
Hum Vaccin Immunother. 2013 Aug;9(8):1763-73
pubmed: 23584253
Ann Intern Med. 2020 Jul 21;173(2):120-136
pubmed: 32369541
N Engl J Med. 2020 Dec 31;383(27):2677-2678
pubmed: 33301245
EBioMedicine. 2015 Jun 23;2(8):891-7
pubmed: 26425696
Nat Med. 2021 Feb;27(2):225-228
pubmed: 33082575
Proc Natl Acad Sci U S A. 2014 Aug 26;111(34):12283-7
pubmed: 25136134
PLoS One. 2020 Sep 3;15(9):e0238414
pubmed: 32881933
JAMA. 2020 Jun 23;323(24):2460-2461
pubmed: 32453392
Lancet. 2011 Aug 6;378(9790):526-35
pubmed: 21664679
N Engl J Med. 2020 Dec 31;383(27):2603-2615
pubmed: 33301246
N Engl J Med. 2021 Feb 18;384(7):e23
pubmed: 33406324

Auteurs

Francesco Di Gennaro (F)

Clinic of Infectious Diseases, University of Bari, 70121 Bari, Italy.

Rita Murri (R)

Clinic of Infectious Diseases, Catholic University of the Sacred Heart, 00168 Rome, Italy.
Dipartimento di Scienze di Laboratorio e Infettivologiche, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy.

Francesco Vladimiro Segala (FV)

Clinic of Infectious Diseases, Catholic University of the Sacred Heart, 00168 Rome, Italy.

Lorenzo Cerruti (L)

Dipartimento di medicina, University of Padua, 35121 Padua, Italy.

Amina Abdulle (A)

Division of Gastroenterology and Hepatology, Città della Salute e della Scienza di Torino Hospital, University of Turin, 10124 Turin, Italy.

Annalisa Saracino (A)

Clinic of Infectious Diseases, University of Bari, 70121 Bari, Italy.

Davide Fiore Bavaro (DF)

Clinic of Infectious Diseases, University of Bari, 70121 Bari, Italy.

Massimo Fantoni (M)

Clinic of Infectious Diseases, Catholic University of the Sacred Heart, 00168 Rome, Italy.
Dipartimento di Scienze di Laboratorio e Infettivologiche, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH